Localized scleroderma: clinical spectrum and therapeutic update
An. bras. dermatol
;
90(1): 62-73, Jan-Feb/2015. tab, graf
Article
in English
| LILACS
| ID: lil-735732
ABSTRACT
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma. In this review, we report the most important aspects and particularities in the treatment of patients diagnosed with localized scleroderma.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Scleroderma, Localized
/
Skin
Type of study:
Etiology study
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2015
Type:
Article
/
Project document
Affiliation country:
Brazil
Institution/Affiliation country:
University of São Paulo/BR
Similar
MEDLINE
...
LILACS
LIS